Exagen Inc.
Exagen Inc. (XGN) Stock Overview
Explore Exagen Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
83.9M
P/E Ratio
-4.03
EPS (TTM)
$-0.93
ROE
-1.38%
XGN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Exagen Inc. (XGN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 41.33, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $12.28.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.03 and a market capitalization of 83.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.